Copies of extracts of Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2025 in Financial Express (English Newspaper) all editions and Nava Telangana (Telugu Newspaper), Hyderabad edition.

pdf

Zenotech Laboratories Ltd.

26 Apr 2025

61.39

1.14%

Corp. Note

Zenotech Laboratories Ltd - 532039 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for the quarter and financial year ended March 31, 2025

pdf

Zenotech Laboratories Ltd.

25 Apr 2025

61.39

1.14%

Board Meeting

Zenotech Laboratories Ltd - 532039 - Board Meeting Outcome for Audited Financial Results Of The Company …

BSE India

Submission of Audited Financial Results of the Company for the quarter and financial year ended March 31, 2025

pdf

Zenotech Laboratories Ltd.

25 Apr 2025

61.39

1.14%

Result

Zenotech Laboratories Ltd - 532039 - Audited Financial Results For The Quarter And Financial Year Ended …

BSE India

Pursuant to Regulation 33 & 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we enclose herewith the following: 1. the Standalone Audited Financial Results of the Company for the quarter and financial year ended March 31, 2025 together with the Report of Auditors'' on the said Results, duly approved and taken on record by the Board of Directors of the Company at their meeting held today, i.e., April 25, 2025; and 2. Declaration under Regulation 33(3)(d) of SEBI LODR.

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	12.62	11.61	9.43	8.7%	33.8%
Operating Profit Qtr	4.47	2.85	1.76	56.8%	154.0%
Net Profit Qtr	1.23	1.69	0.68	-27.2%	80.9%
Earning Per Share Adjusted latest Qtr	0.20	0.28	0.11	-28.6%	81.8%

* Standalone data

Detailed Results

Zenotech Laboratories Ltd.

21 Apr 2025, 04:24PM

61.39

1.14%

Board Meeting

Zenotech Laboratories Ltd - 532039 - Board Meeting Intimation for Considering And Approving Audited Standalone Financial …

BSE India

Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 ,inter alia, to consider and approve Audited Standalone Financial Results for the quarter and financial year ended March 31, 2025.

pdf

Zenotech Laboratories Ltd.

15 Apr 2025

61.39

1.14%

Company Update

Zenotech Laboratories Ltd - 532039 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Submission of Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025.

pdf